Talbot George Harrison

Insider CIK 1554194 · NBRV Director · NBRV Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
NBRV Nabriva Therapeutics plc	A Award deriv	2020-07-29	2020-07-31	35,000	—	$0	35,000	SEC↗
NBRV Nabriva Therapeutics plc	A Award	2020-07-29	2020-07-31	17,500	—	$0	65,140	SEC↗
NBRV Nabriva Therapeutics plc	A Award deriv	2019-07-31	2019-08-01	35,000	—	$0	35,000	SEC↗
NBRV Nabriva Therapeutics plc	P Buy	2018-07-31	2018-08-02	14,500	$2.75	$39.9K	47,640	SEC↗
NBRV Nabriva Therapeutics plc	A Award deriv	2018-05-02	2018-05-04	29,000	—	$0	29,000	SEC↗
NBRV Nabriva Therapeutics plc	M Exercise deriv	2017-09-27	2017-09-29	1,350	—	$0	0	SEC↗
NBRV Nabriva Therapeutics plc	M Exercise	2017-09-27	2017-09-29	1,350	—	$0	33,140	SEC↗
NBRV Nabriva Therapeutics plc	A Award deriv	2017-09-15	2017-09-19	10,100	—	$0	10,100	SEC↗
NBRV Nabriva Therapeutics Plc	J Other deriv	2017-06-23	2017-06-27	40,000	—	$0	40,000	SEC↗
NBRV Nabriva Therapeutics Plc	J Other deriv	2017-06-23	2017-06-27	10,100	—	$0	10,100	SEC↗
NBRV Nabriva Therapeutics Plc	J Other	2017-06-23	2017-06-27	31,790	—	$0	31,790	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-06-19	2017-06-19	46	$91.00	$4.2K	3,179	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-06-16	2017-06-19	24	$93.50	$2.2K	3,225	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-06-15	2017-06-19	100	$94.10	$9.4K	3,249	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-30	2017-06-01	110	$101.50	$11.2K	3,449	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-30	2017-06-01	100	$101.00	$10.1K	3,349	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-25	2017-05-25	90	$101.00	$9.1K	3,559	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-25	2017-05-25	205	$100.50	$20.6K	3,649	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-23	2017-05-25	30	$99.70	$3.0K	3,854	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-16	2017-05-17	50	$102.27	$5.1K	3,984	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-16	2017-05-17	100	$103.00	$10.3K	3,884	SEC↗
NBRV Nabriva Therapeutics AG	S Sale	2017-05-15	2017-05-17	50	$101.50	$5.1K	4,034	SEC↗
NBRV Nabriva Therapeutics AG	M Exercise deriv	2017-02-16	2017-05-17	155	—	$0	0	SEC↗
NBRV Nabriva Therapeutics AG	M Exercise deriv	2017-02-16	2017-05-17	578	—	$0	135	SEC↗
NBRV Nabriva Therapeutics AG	M Exercise deriv	2017-02-16	2017-05-17	502	—	$0	0	SEC↗
NBRV Nabriva Therapeutics AG	M Exercise	2017-02-16	2017-05-17	578	—	$0	4,084	SEC↗
NBRV Nabriva Therapeutics AG	M Exercise	2017-02-16	2017-05-17	502	—	$0	3,351	SEC↗
NBRV Nabriva Therapeutics AG	M Exercise	2017-02-16	2017-05-17	155	—	$0	3,506	SEC↗